UNSPSC 51361936: Pentobarbital sodium

This classification denotes a barbiturate with the molecular formula C11H17N2O3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NJJ0475N0S, chemically known as 2,4,6 (1h,3h,5h)-pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, monosodium salt but more generally known as pentobarbital sodium, which bears US NIH Compound Identifier 4737. European Medicines Agency schedules Pentobarbital sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03691MIG.

Most nations, for tariff and trade purposes, schedule pentobarbital sodium under HS 29335300. As of Q4 2014, PENTOBARBITAL SODIUM remains US FDA's Preferred Term for this commodity. Pentobarbital sodium bears US NLM identifiers UMLS ID C0700349 and NCI Concept Code C47662. SMILES: CCCC(C)C1(C(=O)NC(=O)[N-]C1=O)CC.[NA+].

UNSPSC 51361936 Pentobarbital sodium is a Commodity code that in recent state and local procurement activity maps poorly to its nominal scope. The three most recent opportunities posted under this code—Seminole County's naloxone and drug deactivation systems procurement, Texas HHS's direct-to-manufacturer pharmacy initiative RFI, and MMCAP's generic multi-source pharmaceuticals and OTC products RFP—do not actually solicit pentobarbital sodium. Issuing bodies across the opportunities span county health departments, state health and human services agencies, and multistate cooperative purchasing alliances, but the work being procured consists of emergency overdose-reversal drugs, pharmacy benefit program infrastructure, and broad-spectrum generic pharmaceutical distribution rather than the specific controlled substance the code nominates. This mismatch suggests the code sees limited relevant recent activity or that agencies are mistagging opportunities in their procurement systems.

The geographic spread of recent postings includes Florida (Seminole County), Texas (HHS Commission), and Minnesota (MMCAP, which extends to Oregon as a participant). The Seminole County IFB (S1070000015802, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries. Texas HHS issued RFI HHS0017013 (posted April 3, 2026, response due April 3, 2026) as an exploratory information-gathering mechanism on direct-to-manufacturer prescription fulfillment models. MMCAP issued RFP S1070000015802 (due March 26, 2026) for generic pharmaceuticals and OTC products distributed through three authorized wholesalers to multiple state and local facilities, with award effectiveness set for July 1, 2026. If your firm supplies pentobarbital sodium specifically, this code's recent activity does not support active demand in state and local markets under this taxonomy node.